Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Mutations in the ATP-binding cassette transporter ABCA1 underlie Tangier disease and familial hypoalphaliproteinemia (FHA), disorders that are characterised by reduced high-density lipoprotein-cholesterol (HDL-C) concentration and cholesterol efflux, and increased coronary artery disease (CAD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP279468.RAYUF-N1EjO81SHjPsYjCXwrCWzNmaLCp8GzIQxxKL-3w130_assertion description "[Mutations in the ATP-binding cassette transporter ABCA1 underlie Tangier disease and familial hypoalphaliproteinemia (FHA), disorders that are characterised by reduced high-density lipoprotein-cholesterol (HDL-C) concentration and cholesterol efflux, and increased coronary artery disease (CAD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP279468.RAYUF-N1EjO81SHjPsYjCXwrCWzNmaLCp8GzIQxxKL-3w130_provenance.
• NP724030.RAaB3EqL2KcUa8fcJ3OA7Dph8hUP9rLHH4VVcCNJnquaM130_assertion description "[Mutations in the ATP-binding cassette transporter ABCA1 underlie Tangier disease and familial hypoalphaliproteinemia (FHA), disorders that are characterised by reduced high-density lipoprotein-cholesterol (HDL-C) concentration and cholesterol efflux, and increased coronary artery disease (CAD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP724030.RAaB3EqL2KcUa8fcJ3OA7Dph8hUP9rLHH4VVcCNJnquaM130_provenance.
• assertion description "[Mutations in the ATP-binding cassette transporter ABCA1 underlie Tangier disease and familial hypoalphaliproteinemia (FHA), disorders that are characterised by reduced high-density lipoprotein-cholesterol (HDL-C) concentration and cholesterol efflux, and increased coronary artery disease (CAD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Mutations in the ATP-binding cassette transporter ABCA1 underlie Tangier disease and familial hypoalphaliproteinemia (FHA), disorders that are characterised by reduced high-density lipoprotein-cholesterol (HDL-C) concentration and cholesterol efflux, and increased coronary artery disease (CAD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP195076.RAak9ysFzHUEkaierV2CUE-wZLItbbQwYtHzKs70L-ozA130_assertion description "[Mutations in the ATP-binding cassette transporter ABCA1 underlie Tangier disease and familial hypoalphaliproteinemia (FHA), disorders that are characterised by reduced high-density lipoprotein-cholesterol (HDL-C) concentration and cholesterol efflux, and increased coronary artery disease (CAD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP195076.RAak9ysFzHUEkaierV2CUE-wZLItbbQwYtHzKs70L-ozA130_provenance.
• NP553567.RA2WyRWkkxFaiYctSCwUWeuNRsokocy432Jwea4k_61MA130_assertion description "[Mutations in the ATP-binding cassette transporter ABCA1 underlie Tangier disease and familial hypoalphaliproteinemia (FHA), disorders that are characterised by reduced high-density lipoprotein-cholesterol (HDL-C) concentration and cholesterol efflux, and increased coronary artery disease (CAD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP553567.RA2WyRWkkxFaiYctSCwUWeuNRsokocy432Jwea4k_61MA130_provenance.
• NP881778.RAFb0nyHV5rB-I-2pDVuu16Y-vA5LA4Oc2x-Zxw9skB9U130_assertion description "[Mutations in the ATP-binding cassette transporter ABCA1 underlie Tangier disease and familial hypoalphaliproteinemia (FHA), disorders that are characterised by reduced high-density lipoprotein-cholesterol (HDL-C) concentration and cholesterol efflux, and increased coronary artery disease (CAD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881778.RAFb0nyHV5rB-I-2pDVuu16Y-vA5LA4Oc2x-Zxw9skB9U130_provenance.
• NP392013.RAS4DlCsINSou5CBxmJquiLVbDRs5k_bGwuOY7d3KmcdE130_assertion description "[Mutations in the ATP-binding cassette transporter ABCA1 underlie Tangier disease and familial hypoalphaliproteinemia (FHA), disorders that are characterised by reduced high-density lipoprotein-cholesterol (HDL-C) concentration and cholesterol efflux, and increased coronary artery disease (CAD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP392013.RAS4DlCsINSou5CBxmJquiLVbDRs5k_bGwuOY7d3KmcdE130_provenance.
• NP219013.RAoaxqUUb2ThZ5V2SPoE1TpGu2kba56MLyF4XHbJMJaT4130_assertion description "[Mutations in the ATP-binding cassette transporter ABCA1 underlie Tangier disease and familial hypoalphaliproteinemia (FHA), disorders that are characterised by reduced high-density lipoprotein-cholesterol (HDL-C) concentration and cholesterol efflux, and increased coronary artery disease (CAD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219013.RAoaxqUUb2ThZ5V2SPoE1TpGu2kba56MLyF4XHbJMJaT4130_provenance.
• NP392014.RAIFsjCKFWgs_CVk0w27UbPsXqHI1isDGNFzFsGbkfObU130_assertion description "[Mutations in the ATP-binding cassette transporter ABCA1 underlie Tangier disease and familial hypoalphaliproteinemia (FHA), disorders that are characterised by reduced high-density lipoprotein-cholesterol (HDL-C) concentration and cholesterol efflux, and increased coronary artery disease (CAD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP392014.RAIFsjCKFWgs_CVk0w27UbPsXqHI1isDGNFzFsGbkfObU130_provenance.